Map of Pancreatica Walks and Runs

Category Archives: Medical Research

Prolonged Duration of Neoadjuvant Treatment May Confer Big Benefits in Cancer of the Pancreas

The move away from surgical diagnosis to radiographic criteria in many and now even most efforts at the staging of cancer of the pancreas carries a number of somewhat unspoken but profound consequences, one being efforts to find ways to downstage the diagnosis so as to profitably utilize surgery in locally advanced and borderline resectable […]

Share Button

Adjustments to the FOLFIRINOX Combination for Improved Tolerability in Pancreatic Cancer

Since the May 12, 2011 New England Journal of Medicine article that reported the possible superiority of the 5-FU based four-drug FOLFIRINOX regimen over gemcitabine in the treatment of metastatic pancreatic cancer (and subsequent FDA approval), researchers have been at work trying to discover the best use of this information – and ways to perhaps […]

Share Button

FOLFIRINOX as Neoadjuvant Therapy for Cancer of the Pancreas

The idea behind treating surgically unresectable and borderline resectable pancreatic cancer with chemotherapy or chemoradiation is that some minority of cases will thereupon improve to the point of now being deemed amenable to surgery, with its typically more favorable outcome.  This is generally the point then of so-called neoadjuvant therapy. As the 5-FU based four-drug […]

Share Button
Page 10 of 18« First...89101112...Last »